echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Front Pharmacol: Fenofibrate can reduce SARS-CoV-2 infection rate by up to 70%

    Front Pharmacol: Fenofibrate can reduce SARS-CoV-2 infection rate by up to 70%

    • Last Update: 2021-08-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In a new study, researchers from the University of Birmingham, the University of Keele, the University of Liverpool, the University of Copenhagen, Denmark, and the San Rafael Institute of Science in Italy have discovered in the laboratory a substance commonly used to treat fatty substances in the blood Abnormal levels of approved drugs can reduce infections caused by the SARS-CoV-2 virus by up to 70%


    These authors confirmed that fenofibrate and its active form (fenofibrate acid) can significantly reduce SARS-CoV-2 infection in human cells in the laboratory


    The authors are now calling for clinical trials to test the drug in hospitalized COVID-19 patients


    SARS-CoV-2 is a coronavirus that causes COVID-19


    ACE2 dimerization determination, the picture is from Frontiers in Pharmacology, 2021, doi:10.


    Note: The original text has been deleted

    Reference materials:

    Scott P.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.